AXON AXON ENTERPRISE, INC.
Ordnance & Accessories, (No Vehicles/Guided Missiles) · Nasdaq · SEC CIK 1069183 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY33.6%
TTM net income YoY0.5%
TTM EPS YoY-1.6%
Revenue 3-yr CAGR32.6%
Net income 3-yr CAGR20.5%
Margins
Gross margin58.5%
Operating margin2.0%
Net margin7.6%
FCF margin2.4%
EBITDA margin5.6%
Returns
ROE7.6%
ROA3.3%
ROIC (approx.)1.5%
Asset turnover0.44x
Leverage & solvency
Liabilities / assets57.4%
Debt / equity0.76x
Current ratio3.00x
Interest coverage0.60x
Cash quality & payout
Operating cash flow / net income0.87x
Accruals ratio0.4%
Payout ratio—
Capex / revenue4.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.78B | $2.08B |
| Cost of revenue | $1.12B | $841.15M |
| Gross profit | $1.66B | $1.24B |
| R&D expense | $684.31M | $441.59M |
| SG&A expense | $1.04B | $741.25M |
| Operating income | -$62.08M | $58.54M |
| Interest expense | $94.24M | $7.10M |
| Pretax income | $18.97M | $381.50M |
| Income tax | -$105.68M | $4.47M |
| Net income | $124.66M | $377.03M |
| EBITDA | $21.09M | $106.97M |
| EPS (basic) | 1.60 | 4.98 |
| EPS (diluted) | 1.51 | 4.80 |
| Weighted avg. shares (diluted) | 82.37M | 78.56M |
| Balance sheet | ||
| Cash & equivalents | $1.20B | $466.76M |
| Short-term investments | $505.42M | $333.24M |
| Inventory | $341.81M | $265.32M |
| Current assets | $3.71B | $2.30B |
| PP&E, net | $330.98M | $247.32M |
| Goodwill | $1.37B | $756.84M |
| Intangibles | $196.97M | $175.16M |
| Total assets | $7.00B | $4.47B |
| Current liabilities | $1.47B | $1.68B |
| Short-term debt | $80.55M | $680.29M |
| Long-term debt | $1.73B | $0 |
| Total debt | $1.81B | $680.29M |
| Total liabilities | $3.76B | $2.15B |
| Shareholders' equity | $3.24B | $2.33B |
| Net debt | $609.58M | $213.53M |
| Shares outstanding | 80.21M | 76.62M |
| Cash flow statement | ||
| Operating cash flow | $211.34M | $408.31M |
| Capital expenditure | $136.26M | $78.78M |
| Free cash flow | $75.08M | $329.53M |
| Investing cash flow | -$724.93M | -$490.57M |
| Financing cash flow | $1.25B | -$45.44M |
| Depreciation & amortization | $83.16M | $48.42M |
| Stock-based compensation | $634.23M | $382.60M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.